Komipharm International Co. Ltd Net Asset Quality Index
Komipharm International Co. Ltd net asset quality index. Komipharm International Co. Ltd (041960) has a Net Asset Quality Index of 53.8% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩133.92 Billion minus total liabilities of ₩61.86 Billion yields net assets of ₩72.06 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of Komipharm International Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Komipharm International Co. Ltd (2011–2025)
Net asset quality index of Komipharm International Co. Ltd from 2011 to 2025. This chart shows how Komipharm International Co. Ltd's Net Asset Quality Index has evolved across 15 annual periods from 2011 to 2025. As of December 2025, the index stands at 53.8%, representing net assets of ₩72.06 Billion against total assets of ₩133.92 Billion KRW. See 041960 book value for net asset value and shareholders' equity analysis.
Komipharm International Co. Ltd Net Asset Quality Index by Year (2011–2025)
Komipharm International Co. Ltd net asset quality index by year from 2011 to 2025. The table below presents the year-by-year Net Asset Quality Index for Komipharm International Co. Ltd from 2011 to 2025, covering 15 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 041960 market cap.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 53.8% | ₩72.06 Billion | ₩133.92 Billion | ₩61.86 Billion | ▲ +0.4 pp |
| 2024 | 53.4% | ₩65.54 Billion | ₩122.77 Billion | ₩57.23 Billion | ▲ +2.8 pp |
| 2023 | 50.6% | ₩60.02 Billion | ₩118.60 Billion | ₩58.58 Billion | ▼ -3.7 pp |
| 2022 | 54.3% | ₩60.63 Billion | ₩111.75 Billion | ₩51.12 Billion | ▼ -3.4 pp |
| 2021 | 57.7% | ₩66.46 Billion | ₩115.26 Billion | ₩48.80 Billion | ▼ -4.9 pp |
| 2020 | 62.6% | ₩76.28 Billion | ₩121.91 Billion | ₩45.64 Billion | ▲ +4.2 pp |
| 2019 | 58.3% | ₩73.28 Billion | ₩125.64 Billion | ₩52.37 Billion | ▼ -8.4 pp |
| 2018 | 66.8% | ₩93.39 Billion | ₩139.90 Billion | ₩46.52 Billion | ▼ -1.1 pp |
| 2017 | 67.8% | ₩101.27 Billion | ₩149.27 Billion | ₩48.00 Billion | ▲ +5.6 pp |
| 2016 | 62.2% | ₩93.20 Billion | ₩149.84 Billion | ₩56.64 Billion | ▲ +5.1 pp |
| 2015 | 57.1% | ₩76.13 Billion | ₩133.39 Billion | ₩57.26 Billion | ▲ +14.3 pp |
| 2014 | 42.7% | ₩53.16 Billion | ₩124.40 Billion | ₩71.24 Billion | ▲ +1.6 pp |
| 2013 | 41.1% | ₩44.72 Billion | ₩108.80 Billion | ₩64.08 Billion | ▼ -11.6 pp |
| 2012 | 52.7% | ₩40.56 Billion | ₩76.98 Billion | ₩36.41 Billion | ▼ -8.5 pp |
| 2011 | 61.2% | ₩39.24 Billion | ₩64.12 Billion | ₩24.88 Billion | — |